Research Article
Novel Predictive Scoring System for Intravenous Immunoglobulin Resistance Helps Timely Intervention in Kawasaki Disease: The Chinese Experience
Table 1
Comparison of clinical and laboratory variables between IVIG responders and IVIG nonresponders.
| Variables | IVIG responders n = 665 | IVIG nonresponders n = 38 | P values |
| Male | 403 (60.60%) | 26 (68.42%) | 0.336 | Age (month) | 26.54 ± 21.39 | 32.24 ± 31.47 | 0.278 | ESR (mm/hr) | 63.63 ± 26.30 | 72.26 ± 37.15 | 0.166 | BNP (pg/mL) | 159.72 ± 199.13 | 403.72 ± 840.81 | 0.091 | PCT (ng/mL) | 1.13 ± 1.81 | 2.70 ± 4.44 | 0.036 | SF (ng/mL) | 169.84 ± 141.99 | 294.01 ± 238.23 | 0.003 | T lymphocyte (/μL) | 2,147.40 ± 1,153.44 | 1,446.33 ± 1,064.17 | 0.001 | CD4+ T lymphocyte (/μL) | 1,368.83 ± 830.40 | 912.50 ± 745.04 | 0.002 | SIL-2R (U/mL) | 2,187.97 ± 1,435.44 | 3,293.73 ± 2,469.47 | 0.021 | IL-6 (pg/mL) | 39.24 ± 76.48 | 98.13 ± 162.75 | 0.058 | ALT (U/L) | 35.51 ± 49.80 | 69.63 ± 92.54 | 0.030 | AST (U/L) | 38.66 ± 42.57 | 54.89 ± 67.68 | 0.152 | Albumin (g/L) | 37.09 ± 4.40 | 32.31 ± 5.18 | | Total bilirubin (μmol/L) | 6.39 ± 5.89 | 13.39 ± 14.16 | 0.004 | Direct bilirubin (μmol/L) | 2.83 ± 4.00 | 8.76 ± 11.98 | 0.004 | Sodium (mmol/L) | 135.95 ± 2.5 | 134.21 ± 3.01 | | CRP (mg/L) | 51.17 ± 44.50 | 86.37 ± 65.68 | 0.002 | WBC (×109/L) | 11.84 ± 5.21 | 19.89 ± 9.92 | | Percentage of neutrophils (%) | 51.28 ± 19.82 | 72.96 ± 14.98 | | Hb (g/L) | 106.72 ± 10.81 | 101.08 ± 10.57 | 0.002 | Plt (×109/L) | 385.37 ± 127.59 | 334.45 ± 164.30 | 0.019 |
|
|
Data is presented as number (%) or mean ± standard deviation.
|